|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 3.640 CNY | +1.11% |
|
+0.83% | -8.54% |
| Market Cap | 2.86B 426M 378M 353M 322M 607M 40.94B 613M 4.27B 1.66B 20.93B 1.6B 1.56B 67.16B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 3.07B 458M 407M 380M 346M 653M 44.05B 659M 4.6B 1.78B 22.52B 1.72B 1.68B 72.27B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.11% | ||
| 1 week | +0.83% | ||
| 1 month | -12.29% | ||
| 3 months | +17.04% | ||
| 6 months | -16.51% | ||
| Current year | -8.54% |
| 1 week | 3.52 |  | 3.68 |
| 1 month | 3.45 | | 3.98 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 13/05/2021 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 06/09/2024 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 17/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 22/01/2009 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 21/02/2011 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 03/01/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | +0.83% | -10.78% | -37.24% | 425M | |
| -0.39% | -3.34% | +39.53% | +112.52% | 1,025B | |
| -1.26% | -5.80% | +37.37% | +64.67% | 623B | |
| +0.95% | -0.80% | +10.85% | +76.87% | 459B | |
| -0.19% | -3.58% | +60.26% | +39.88% | 355B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 336B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 270B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 247B | |
| -0.79% | -2.60% | +35.78% | +51.63% | 220B | |
| -2.13% | -4.40% | +30.51% | +94.73% | 183B | |
| Average | -0.70% | -1.79% | +23.23% | +47.54% | 371.86B | |
| Weighted average by Cap. | -0.72% | -2.11% | +30.37% | +68.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 324M 288M 269M 245M 462M 31.17B 467M 3.25B 1.26B 15.94B 1.22B 1.19B 51.14B | 1.86B 278M 247M 230M 210M 396M 26.71B 400M 2.79B 1.08B 13.65B 1.04B 1.02B 43.82B |
| Net income | -317M -47.31M -42.04M -39.23M -35.76M -67.44M -4.55B -68.07M -475M -184M -2.33B -178M -174M -7.46B | -330M -49.15M -43.67M -40.76M -37.15M -70.07M -4.73B -70.72M -493M -191M -2.42B -185M -181M -7.75B |
| Net Debt | 411M 61.28M 54.45M 50.82M 46.32M 87.36M 5.89B 88.17M 615M 238M 3.01B 230M 225M 9.67B | 217M 32.38M 28.77M 26.85M 24.48M 46.16M 3.11B 46.59M 325M 126M 1.59B 122M 119M 5.11B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥3.640 | +1.11% | 18,112,612 |
| 29/09/26 | CN¥3.600 | -.--% | 14,816,712 |
| 28/09/26 | CN¥3.600 | -0.28% | 14,389,265 |
| 24/09/26 | CN¥3.610 | -1.63% | 15,858,800 |
| 23/09/26 | CN¥3.670 | -2.91% | 24,958,161 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
